Status:
UNKNOWN
Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria.
Lead Sponsor:
Olivier Michel
Conditions:
Chronic Urticaria
Eligibility:
All Genders
18+ years
Brief Summary
Chronic urticaria (CU) is a disease that usually affects a large visible amount of surface of the skin. It is accompanied by severe itch and feeling of burned skin. Therefore the disease has a big imp...
Detailed Description
Chronic urticaria (CU) is an inflammatory skin disease that is defined by the presence of urticaria (hives), on most days of the week, for a period of six weeks or longer. About 40 percent of patients...
Eligibility Criteria
Inclusion
- All patients diagnosed with chronic urticaria receiving medical care within the CHU Brugmann Hospital. Diagnose performed according to the European Academy of Allergy and Clinical Immunology (EAACI) guidelines.
Exclusion
- None
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03443362
Start Date
February 1 2018
End Date
December 1 2022
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020